🔎 Trials Near Me

Akèy › Kansè vejik › Kentucky › Lexington

Etid klinik pou Kansè vejik nan Lexington, KY

7 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Lexington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • CommonSpirit Saint Joseph Hospital - Lexington, Lexington
  • Saint Joseph Radiation Oncology Resource Center, Lexington
  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Ap rekriteFaz 2
  • University of Kentucky/Markey Cancer Center, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • University of Kentucky/Markey Cancer Center, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Ap rekriteFaz 3
  • University of Kentucky/Markey Cancer Center, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07097142

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Ap rekriteFaz 2/3
  • University of Kentucky Chandler Medical Center, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT07106762

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Ap rekriteFaz 1
  • University of Kentucky Markey Cancer Center, Lexington
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT06778863

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Baptist Lexington, Lexington
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Etid Kansè vejik nan lòt vil

Lòt etid nan Lexington

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.